References
- Ohga E, Tomita T, Wada H, et al. Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol. 1985;2003(94):179–184.
- Marrone O, Salvaggio A, Bue AL, et al. Blood pressure changes after automatic and fixed CPAP in obstructive sleep apnea: relationship with nocturnal sympathetic activity. Clin Exp Hypertens. 2011;33:373–380.
- Freire AX, Kadaria D, Avecillas JF, et al. Obstructive sleep apnea and immunity: relationship of lymphocyte count and apnea hypopnea index. South Med J. 2010;103:771–774.
- Min JY, Jang JY, Kim HY, et al. Relationship between the obstructive sleep apnea syndrome and the erythrocyte sedimentation rate. Clin Exp Otorhinolaryngol. 2009;2:126–130.
- Ciftci TU, Kokturk O, Bukan N, et al. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine. 2004;21:87–91.
- Steiropoulos P, Papanas N, Nena E, et al. Inflammatory markers in middle-aged obese subjects: does obstructive sleep apnea syndrome play a role? Mediators Inflamm. 2010;2010:675320.
- Saletu M, Nosiska D, Kapfhammer G, et al. Structural and serum surrogate markers of cerebrovascular disease in obstructive sleep apnea (OSA): association of mild OSA with early atherosclerosis. J Neurol. 2006;253:746–752.
- Schwartz AR, Patil SP, Laffan AM, et al. Obesity and obstructive sleep apnea pathogenic mechanisms and therapeutic approaches. Proc Am Thorac Soc. 2008;5:185–192.
- Piva SJ, Duarte MM, Da Cruz IB, et al. Ischemia-modified albumin as an oxidative stress biomarker in obesity. Clin Biochem. 2011;44:345–347.
- Yang L-X, Shao-Gang M, Hong L, et al. Influence of obstructive sleep apnea on serum butyrylcholinesterase activity and ischemia-modified albumin levels. Clinics. 2013;68:968–973.
- Oztuna F, Gozacan H, Kiris G, et al. Effect of nasal continuous positive airway pressure on global right ventricular myocardial performance in patients with obstructive sleep apnea syndrome. Turk J Med Sci. 2013;43:393–399.
- Berry RB, Budhiraja R, Gottlieb DJ, et al. American academy of sleep medicine. Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. deliberations of the sleep apnea definitions task force of the American academy of sleep medicine. J Clin Sleep Med. 2012;8:597–619.
- WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–163.
- Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemiada preliminary report. J Emerg Med. 2000;19:311–315.
- Lippi G, Montagnana M, Guidi GC. Albumin cobalt binding and ischemia modified albumin generation: an endogenous response to ischemia? Int J Cardiol. 2006;108:410–411.
- Burioka N, Koyanagi S, Fukuoka Y, et al. Influence of intermittent hypoxia on the signal transduction pathways to inflammatory response and circadian clock regulation. Life Sci. 2009;85:372–378.
- Greenberg H, Ye X, Wilson D, et al. Chronic intermittent hypoxia activates nuclear factor-κB in cardiovascular tissues in vivo. Biochem Biophys Res Commun. 2006;343:591–596.
- Nadeem R, Molnar J, Madbouly EM, et al. Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. J Clin Sleep Med. 2013;9:1003–1012.
- Alves Eda S, Ackel-D’Elia C, Luz GP, et al. Does physical exercise reduce excessive daytime sleepiness by improving inflammatory profiles in obstructive sleep apnea patients? Sleep Breath. 2013;17:505–510.
- Lira FS, Rosa JC, Dos Santos RV, et al. Visceral fat decreased by long-term interdisciplinary lifestyle therapy correlated positively with interleukin-6 and tumor necrosis factor-α and negatively with adiponectin levels in obese adolescents. Metabolism. 2011;60:359–365.
- Kanda T, Inoue M, Kotajima N, et al. Circulating interleukin-6 and interleukin-6 receptors in patients with acute and recent myocardial infarction. Cardiology. 2000;93:191–196.
- Ueda K, Takahashi M, Ozawa K, et al. Decreased soluble interleukin-6 receptor in patients with acute myocardial infarction. Am Heart J. 1999;138(5):908–915.
- Arnardottir ES, Maislin G, Schwab RJ, et al. The interaction of obstructive sleep apnea and obesity on the inflammatory markers c-reactive protein and interleukin-6: the Icelandic Sleep Apnea Cohort. Sleep. 2012;35:921–932.
- Pou KM, Massaro JM, Hoffmann U, et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation. 2007;116:1234–1241.
- Abboud H, Labreuche J, Meseguer E, et al. Ischemia-modified albumin in acute stroke. Cerebrovasc Dis. 2007;23:216–220.
- Karamanli H, Kiyici A, Arik B, et al. Influence of obstructive sleep apnea on ischemia-modified albumin levels and carotid intima-media thickness. J Investig Med. 2016;64:1035–1041.
- Sunnetcioglu A, Asker S, Alp HH, et al. Increased asymmetric dimethylarginine and ıschemia-modified albumin levels in obstructive sleep apnea. Respir Care. 2016 Apr 19. pii: respcare.04472 [Epub ahead of print].
- Uygur F, Tanriverdi H, Can M, et al. The ımpact of obstructive sleep apnoea and nasal continuous positive airway pressure on circulating ıschaemia-modified albumin concentrations. Mediators Inflamm. 2016;2016:8907314.
- Ozben S, Huseyinoglu N, Hanikoglu F, et al. Advanced oxidation protein products and ischaemia-modified albumin in obstructive sleep apnea. Eur J Clin Invest. 2014;44:1045–1052.